Financhill
Back

Actinium Pharmaceuticals, Inc. Stock Price Chart

This Tech Company Grew 32,481%...

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
29

ATNM
Actinium Pharmaceuticals, Inc.

Last Price:
$1.38
Seasonality Move:
102.85%

7 Day Trial

ALL ACCESS PASS

$ 7
  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ATNM is experiencing selling pressure, which indicates risk of future bearish movement.

Actinium Pharmaceuticals, Inc. Price Chart Indicators

Moving Averages Level Buy or Sell
8-day SMA: 1.57 Sell
20-day SMA: 1.49 Sell
50-day SMA: 1.44 Sell
200-day SMA: 1.53 Sell
8-day EMA: 1.53 Sell
20-day EMA: 1.5 Sell
50-day EMA: 1.48 Sell
200-day EMA: 1.68 Sell

Actinium Pharmaceuticals, Inc. Technical Analysis Indicators

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.04 Buy
Relative Strength Index (14 RSI): 44.85 Sell
Chaikin Money Flow: -141583 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (1.37 - 1.57) Sell
Bollinger Bands (100): (1.4 - 1.66) Sell

Actinium Pharmaceuticals, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Technical Analysis for Actinium Pharmaceuticals, Inc. Stock

Is Actinium Pharmaceuticals, Inc. Stock a Buy?

ATNM Technical Analysis vs Fundamental Analysis

Sell
29
Actinium Pharmaceuticals, Inc. (ATNM) is a Sell

Is Actinium Pharmaceuticals, Inc. a Buy or a Sell?

Actinium Pharmaceuticals, Inc. Stock Info

Market Cap:
44.3M
Price in USD:
1.42
Share Volume:
173K

Actinium Pharmaceuticals, Inc. 52-Week Range

52-Week High:
2.41
52-Week Low:
1.03
Sell
29
Actinium Pharmaceuticals, Inc. (ATNM) is a Sell

Actinium Pharmaceuticals, Inc. Share Price Forecast

Is Actinium Pharmaceuticals, Inc. Stock a Buy?

Fundamental Analysis of Actinium Pharmaceuticals, Inc.

Is Actinium Pharmaceuticals, Inc. a good investment?

  • Analysts estimate an earnings increase this quarter of $0.18 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.34 per share, and a decrease next year of $0.00 per share.

Technical Analysis of Actinium Pharmaceuticals, Inc.

Should I short Actinium Pharmaceuticals, Inc. stock?

* Actinium Pharmaceuticals, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.